Unjha Formulations Share Price

Unjha Formulations Limited was established in June, 1987 as a Partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. The Company is a pioneer in Isabgol (Psyllium) Formulation. The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc. It is one of the largest manufacturers of isabgul products in India. The companys products are classified under two divisions human consumption and veterinary products. Company launched four new products viz.Bericof, ProtobalNT, Formentin Tablets and Nalizole in the year 199798. The Company commenced its commercial production and was successfully expanding its customer base throughout the Country including U.P. Territory. Company also interested on development of Export Markets for Ferrous Sulphate, Albendazole Bolus and Iron Folic Tablets to supplement the present law domestic demand situation and achieved export turnover of Rs.0.98 during the year 199798. During 200203, the Company made manufacturing agreement with Nicholas Piramal India Limited for sale of Isabgol Husk based product TYBOGEL and Morepen Laboratories Ltd. for sale of Dr.Mopren Sat Isabgol. It had manufacturing agreement with Karnataka Antibiotics Pharmaceuticals Limited for sale of Isabgol Husk based products and other veterinary products on Loan Licence basis.In 2026, the Company made manufacturing agreement with Reckit Benckiser India Ltd., for sales of Isabgol Husk based product Fybogel, Abbot HealthcatePvt Ltd., for sales of FABOLITE Karnataka Antibiotics Pharmaceuticals Ltd for sale of Husky,RadiantNutracetical Bangladesh for exports, Rhine Biogenics Pvt. Ltd for sale of Trugol SF Powder Nutragenix Healthcare Pvt Ltd. for sale of Fibapure Group of product and Appolo Pharmacy for sale of SatIsabgol etc. Company signed further manufacturing agreement with Karnataka Antibiotics Pharmaceuticals Limited for sale of Isabgol Husk based product. It focused on development of Export Markets, for Albendazole Bolus, Fibron SF Powder and Fibermate (Isabgol based formulations) to supplement the present low domestic demand situation.